Related Experiment Video
Updated: Feb 9, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Exploring Therapeutic Potential of Nanocarrier Systems Against Breast Cancer
Lalit Kumar1,2, Ashish Baldi3, Shivani Verma2,4
1Faculty of Pharmaceutical Sciences, Department of Pharmaceutics, PCTE Group of Institutes, Ludhiana, Punjab 142021, India.
Background:
Breast cancer is the most widely occurring non-cutaneous cancer in women. Treatment options available for breast cancer are limited and there are a number of toxicity concerns associated with them. Therefore, nanocarrier based approaches have been explored for breast cancer treatment. Nanocarriers implemented for breast cancer treatment are nanoliposomes, polymeric nanoparticles, solid lipid nanoparticles, nanostructured lipid carriers, gold nanoparticles, dendrimers, and protein nanocages.
Objective:
Objective of this review was to explore the therapeutic efficacy of various nanocarrier systems against breast cancer.
Method:
Existing literature regarding nanocarrier systems for breast cancer therapy was reviewed using Pubmed and Google Scholar.
Results:
Nanocarriers may show prolonged circulation time of chemotherapeutic agent with efficient breast tumor targeting. Both active and passive targeting methodologies can be explored to target breast cancer cells using different nanocarriers. Targeted nanocarriers have the capability to reduce side effects caused by various conventional formulations used to treat breast cancer.
Conclusion:
Various nanocarriers listed above have shown their therapeutic potential in preclinical studies to treat breast cancer. Satisfactory clinical evaluation and scale up techniques can promote their entry into the pharmaceutical market in greater extent.
Insights
Nanocarriers offer promising breast cancer treatment by improving drug delivery and targeting tumor cells. Further clinical evaluation is needed for these advanced nanocarrier systems to reach the pharmaceutical market.
Area of Science:
- Oncology
- Nanotechnology
- Pharmaceutical Sciences
Background:
- Breast cancer is a prevalent cancer in women with limited and toxic treatment options.
- Nanocarrier-based approaches are being investigated to overcome limitations of current breast cancer therapies.
- Various nanocarriers, including liposomes, nanoparticles, and dendrimers, are explored for breast cancer treatment.
Purpose of the Study:
- To review the therapeutic efficacy of diverse nanocarrier systems against breast cancer.
- To explore the potential of nanocarriers in improving breast cancer treatment outcomes.
Main Methods:
- A comprehensive literature review was conducted.
- Databases searched included Pubmed and Google Scholar for relevant studies on nanocarrier systems in breast cancer therapy.
Main Results:
- Nanocarriers can enhance circulation time and target breast tumors effectively.
- Both active and passive targeting strategies using nanocarriers can be employed.
- Targeted nanocarriers show potential in reducing side effects associated with conventional breast cancer treatments.
Conclusions:
- Multiple nanocarriers demonstrate therapeutic potential in preclinical breast cancer studies.
- Clinical evaluation and scalable manufacturing are crucial for pharmaceutical market entry.
- Nanocarrier systems represent a promising advancement in breast cancer therapy.
Related Concept Videos
Therapeutic Index
Second Order systems II
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
First Order Systems
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...
Second Order systems I
By reinterpreting the system, one can derive the closed-loop transfer function, which...
Standard Electrode Potentials

